Thrombolytic Therapy With Streptokinase in Acute Ischemic Stroke - MAST-E

Description:

The Multicenter Acute Stroke Trial-Europe (MAST-E) was a multicenter, prospective, double-blind, controlled trial designed to assess the efficacy and safety of streptokinase in patients with acute ischemic stroke. Follow-up was six months.